Literature DB >> 25034404

Decreased bile-acid synthesis in livers of hepatocyte-conditional NADPH-cytochrome P450 reductase-null mice results in increased bile acids in serum.

Xingguo Cheng1, Youcai Zhang1, Curtis D Klaassen2.   

Abstract

NADPH-cytochrome P450 reductase (Cpr) is essential for the function of microsomal cytochrome P450 monooxygenases (P450), including those P450s involved in bile acid (BA) synthesis. Mice with hepatocyte-specific deletion of NADPH-cytochrome P450 reductase (H-Cpr-null) have been engineered to understand the in vivo function of hepatic P450s in the metabolism of xenobiotics and endogenous compounds. However, the impact of hepatic Cpr on BA homeostasis is not clear. The present study revealed that H-Cpr-null mice had a 60% decrease in total BA concentration in liver, whereas the total BA concentration in serum was almost doubled. The decreased level of cholic acid (CA) in both serum and livers of H-Cpr-null mice is likely due to diminished enzyme activity of Cyp8b1 that is essential for CA biosynthesis. Feedback mechanisms responsible for the reduced liver BA concentrations and/or increased serum BA concentrations in H-Cpr-null mice included the following: 1) enhanced alternative BA synthesis pathway, as evidenced by the fact that classic BA synthesis is diminished but chenodeoxycholic acid still increases in both serum and livers of H-Cpr-null mice; 2) inhibition of farnesoid X receptor activation, which increased the mRNA of Cyp7a1 and 8b1; 3) induction of intestinal BA transporters to facilitate BA absorption from the intestine to the circulation; 4) induction of hepatic multidrug resistance-associated protein transporters to increase BA efflux from the liver to blood; and 5) increased generation of secondary BAs. In summary, the present study reveals an important contribution of the alternative BA synthesis pathway and BA transporters in regulating BA concentrations in H-Cpr-null mice.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25034404      PMCID: PMC4165027          DOI: 10.1124/jpet.114.216796

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  38 in total

1.  Identification of a hormonal basis for gallbladder filling.

Authors:  Mihwa Choi; Antonio Moschetta; Angie L Bookout; Li Peng; Michihisa Umetani; Sam R Holmstrom; Kelly Suino-Powell; H Eric Xu; James A Richardson; Robert D Gerard; David J Mangelsdorf; Steven A Kliewer
Journal:  Nat Med       Date:  2006-10-29       Impact factor: 53.440

2.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

3.  Organic anion-transporting polypeptide 1a4 (Oatp1a4) is important for secondary bile acid metabolism.

Authors:  Youcai Zhang; Iván L Csanaky; Felcy Pavithra Selwyn; Lois D Lehman-McKeeman; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

4.  Organic anion-transporting polypeptide 1b2 (Oatp1b2) is important for the hepatic uptake of unconjugated bile acids: Studies in Oatp1b2-null mice.

Authors:  Iván L Csanaky; Hong Lu; Youcai Zhang; Kenichiro Ogura; Supratim Choudhuri; Curtis D Klaassen
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

5.  The profile of bile acids and their sulfate metabolites in human urine and serum.

Authors:  Sai Praneeth R Bathena; Sandeep Mukherjee; Marco Olivera; Yazen Alnouti
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-10-22       Impact factor: 3.205

Review 6.  Targeting bile-acid signalling for metabolic diseases.

Authors:  Charles Thomas; Roberto Pellicciari; Mark Pruzanski; Johan Auwerx; Kristina Schoonjans
Journal:  Nat Rev Drug Discov       Date:  2008-08       Impact factor: 84.694

7.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

8.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice.

Authors:  Iván L Csanaky; Lauren M Aleksunes; Yuji Tanaka; Curtis D Klaassen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-04       Impact factor: 4.052

9.  Regulation of hepatic bile acid transporters Ntcp and Bsep expression.

Authors:  Xingguo Cheng; David Buckley; Curtis D Klaassen
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

10.  Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice.

Authors:  Youcai Zhang; Pallavi B Limaye; Lois D Lehman-McKeeman; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

View more
  3 in total

1.  Adaptive hepatic and intestinal alterations in mice after deletion of NADPH-cytochrome P450 Oxidoreductase (Cpr) in hepatocytes.

Authors:  Xingguo Cheng; Jun Gu; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2014-08-21       Impact factor: 3.922

2.  Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.

Authors:  Shogo Takahashi; Tatsuki Fukami; Yusuke Masuo; Chad N Brocker; Cen Xie; Kristopher W Krausz; C Roland Wolf; Colin J Henderson; Frank J Gonzalez
Journal:  J Lipid Res       Date:  2016-09-16       Impact factor: 5.922

3.  Effect of Gender and Various Diets on Bile Acid Profile and Related Genes in Mice.

Authors:  Chong Ma; Ying Guo; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2020-10-22       Impact factor: 3.922

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.